# A Pharmacokinetic Study of VCT220 in Particicants With Hepatic Injury and Normal Hepatic Function

> **NCT06938529** · PHASE1 · COMPLETED · sponsor: **Vincentage Pharma Co., Ltd** · enrollment: 24 (actual)

## Conditions studied

- Obesity, Overweight

## Interventions

- **DRUG:** VCT220
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06938529
- **Lead sponsor:** Vincentage Pharma Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-04-18
- **Primary completion:** 2025-07-15
- **Final completion:** 2025-07-25
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2025-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06938529

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06938529, "A Pharmacokinetic Study of VCT220 in Particicants With Hepatic Injury and Normal Hepatic Function". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06938529. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*